Real-world utilisation of ASCT in multiple myeloma (MM): a report from the Australian and New Zealand myeloma and related diseases registry (MRDR)
出版年份 2021 全文链接
标题
Real-world utilisation of ASCT in multiple myeloma (MM): a report from the Australian and New Zealand myeloma and related diseases registry (MRDR)
作者
关键词
-
出版物
BONE MARROW TRANSPLANTATION
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-05-19
DOI
10.1038/s41409-021-01308-8
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study
- (2020) Michele Cavo et al. Lancet Haematology
- Treatment of Multiple Myeloma: ASCO and CCO Joint Clinical Practice Guideline
- (2019) Joseph Mikhael et al. JOURNAL OF CLINICAL ONCOLOGY
- Trends in Autologous Transplantation for Myeloma in EBMT Centres between 1993 and 2017
- (2019) Patrick J Hayden et al. BLOOD
- Investigational agents in immunotherapy: a new horizon for the treatment of multiple myeloma
- (2018) Cindy Varga et al. BRITISH JOURNAL OF HAEMATOLOGY
- Association Between Autologous Stem Cell Transplant and Survival Among Californians With Multiple Myeloma
- (2018) Aaron S Rosenberg et al. JNCI-Journal of the National Cancer Institute
- Safety Outcomes for Autologous Stem Cell Transplant in Multiple Myeloma
- (2018) Morie A. Gertz et al. MAYO CLINIC PROCEEDINGS
- Association Between Autologous Stem Cell Transplant and Survival Among Californians With Multiple Myeloma
- (2018) Aaron S Rosenberg et al. JNCI-Journal of the National Cancer Institute
- Real-life data on safety and efficacy of autologous stem cell transplantation in elderly patients with multiple myeloma
- (2018) Carolina Marini et al. ANNALS OF HEMATOLOGY
- Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma
- (2017) Michel Attal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Novel Immunotherapies for Multiple Myeloma
- (2017) Mattia D’Agostino et al. Current Hematologic Malignancy Reports
- Association of Minimal Residual Disease With Superior Survival Outcomes in Patients With Multiple Myeloma
- (2017) Nikhil C. Munshi et al. JAMA Oncology
- Efficacy and safety of autologous hematopoietic cell transplantation in elderly patients with multiple myeloma: a retrospective national multi-site cohort study
- (2016) Yael C Cohen et al. ANNALS OF HEMATOLOGY
- A Review of Hematopoietic Cell Transplantation in Australia and New Zealand, 2005 to 2013
- (2016) Ian Nivison-Smith et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Design and development of the Australian and New Zealand (ANZ) myeloma and related diseases registry
- (2016) Krystal Bergin et al. BMC Medical Research Methodology
- Autologous stem cell transplant for multiple myeloma patients 70 years or older
- (2016) E Muchtar et al. BONE MARROW TRANSPLANTATION
- Upfront autologous stem cell transplantation for newly diagnosed elderly multiple myeloma patients: a prospective multicenter study
- (2016) Laurent Garderet et al. HAEMATOLOGICA
- Novel agents in the treatment of multiple myeloma: a review about the future
- (2016) Leonard Naymagon et al. Journal of Hematology & Oncology
- A novel BCMA/CD3 bispecific T-cell engager for the treatment of multiple myeloma induces selective lysis in vitro and in vivo
- (2016) S Hipp et al. LEUKEMIA
- Upfront autologous stem cell transplantation for newly diagnosed elderly multiple myeloma patients: a prospective multicenter study
- (2016) Laurent Garderet et al. HAEMATOLOGICA
- Disparities in Utilization of Autologous Hematopoietic Cell Transplantation for Treatment of Multiple Myeloma
- (2015) Luciano J. Costa et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Cost-Effectiveness of Autologous Hematopoietic Stem Cell Transplantation for Elderly Patients with Multiple Myeloma using the Surveillance, Epidemiology, and End Results–Medicare Database
- (2015) Gunjan L. Shah et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report
- (2015) A. Palumbo et al. BLOOD
- Immunotherapy based on bispecific T-cell engager with hIgG1 Fc sequence as a new therapeutic strategy in multiple myeloma
- (2015) Jianxuan Zou et al. CANCER SCIENCE
- Treatment of patients with multiple myeloma who are eligible for stem cell transplantation: position statement of the Myeloma Foundation of Australia Medical and Scientific Advisory Group
- (2015) H. Quach et al. INTERNAL MEDICINE JOURNAL
- The Real World Effectiveness of Hematopoietic Transplant Among Elderly Individuals With Multiple Myeloma
- (2015) Aaron N. Winn et al. JNCI-Journal of the National Cancer Institute
- Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: a randomised, multicentre, phase 3 trial
- (2015) Francesca Gay et al. LANCET ONCOLOGY
- The Real World Effectiveness of Hematopoietic Transplant Among Elderly Individuals With Multiple Myeloma
- (2015) Aaron N. Winn et al. JNCI-Journal of the National Cancer Institute
- Older Patients with Myeloma Derive Similar Benefit from Autologous Transplantation
- (2014) Manish Sharma et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Autologous Transplantation and Maintenance Therapy in Multiple Myeloma
- (2014) Antonio Palumbo et al. NEW ENGLAND JOURNAL OF MEDICINE
- All transplantation-eligible patients with myeloma should receive ASCT in first response
- (2014) P. Moreau et al. Hematology-American Society of Hematology Education Program
- Autologous stem cell transplantation for elderly patients with newly diagnosed multiple myeloma in the era of novel agents
- (2013) M. Merz et al. ANNALS OF ONCOLOGY
- Low Uptake of Upfront Autologous Transplantation for Myeloma in a Jurisdiction With Universal Health Care Coverage: A Population-Based Patterns of Care Study in Australia
- (2013) Nicole Wong Doo et al. Clinical Lymphoma Myeloma & Leukemia
- Minimal Residual Disease Assessed by Multiparameter Flow Cytometry in Multiple Myeloma: Impact on Outcome in the Medical Research Council Myeloma IX Study
- (2013) Andy C. Rawstron et al. JOURNAL OF CLINICAL ONCOLOGY
- Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients
- (2013) S K Kumar et al. LEUKEMIA
- A population-based analysis of the effect of autologous hematopoietic cell transplant in the treatment of multiple myeloma
- (2013) Ian Nivison-Smith et al. LEUKEMIA & LYMPHOMA
- Proteasome inhibitors in multiple myeloma: 10 years later
- (2012) P. Moreau et al. BLOOD
- Impact of age, race and decade of treatment on overall survival in a critical population analysis of 40,000 multiple myeloma patients
- (2011) Hakan Kaya et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Consolidation Therapy With Low-Dose Thalidomide and Prednisolone Prolongs the Survival of Multiple Myeloma Patients Undergoing a Single Autologous Stem-Cell Transplantation Procedure
- (2009) Andrew Spencer et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More